Hemostemix Announces Completion of Phase II Clinical Trial Subject Follow Up and HMTXF Up-list Apr 23, 2021
HempFusion Comments on Recent Trading Activity, All Projects, Incl. Five Channel Strategy, in Motion and Strong Cash-On-Hand Apr 15, 2021
Sanofi Unveils First Global Research Institute in China to Develop Innovative Drugs Apr 14, 2021 Life Science
HempFusion Completes Inflammatory Markers Pilot Trial, Releases White Paper Mar 25, 2021 Life Science
HempFusion Wellness Announces Toxicology Results from Validcare’s Clinical Study on CBD Liver Safety Mar 23, 2021 Life Science
What Does HempFusion Entry onto China’s Ecommerce Giant, Tmall, Mean for Investors? Mar 18, 2021 Life Science
HempFusion Wellness Enters China with Probulin Probiotics Through Alibaba Group’s T-Mall Global, Reaching More Than 750 Million Potential New Consumers Mar 18, 2021 Life Science
HempFusion Is the Top Performing Topical CBD Brand at Major Food-Drug Mass Retailer Mar 9, 2021 Life Science
HempFusion Wellness Submits Novel Foods Dossier to the United Kingdom’s Regulatory Food Safety Agency Mar 3, 2021 Life Science
NAI500 Special Coverage: With Global CBD Legislations Solidifying, is the Industry at a Tipping Point for Investors? Mar 2, 2021 Cannabis, Life Science
HempFusion Wellness Announces Broadening of Share Liquidity With DTC Full-Service Eligibility Feb 26, 2021 Cannabis, Life Science
Healthcare Roundup – FDA says COVID-19 vaccines targeting variants won’t need lengthy trials; Recreational marijuana use officially legalized in New Jersey Feb 23, 2021 Life Science
Global CBD Consumers Continue to Gain More Offerings as Market Regulations Around the World Solidify Feb 17, 2021 Life Science
HempFusion CBD to be the Exclusive Supplier for Clinical Trial at Mount Sinai Medical Hospital, New York Feb 17, 2021 Life Science
Healthcare Roundup – Sesen price target raised on prospects for bladder cancer therapy; Sundial makes $22M investment in cannabis edibles company Indiva Feb 16, 2021 Life Science
